Malignant malenoma

745 views 35 slides May 29, 2020
Slide 1
Slide 1 of 35
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35

About This Presentation

detail description of malignant melanoma


Slide Content

MALIGNANT
MELANOMA
Ms. SAHELI C
LECTURER
IACN

INTRODUCTION
•Malignant melanoma accounting for about 3 to 4 % of all
diagnosed skin cancers.
•Melanoma begins in the melanocytescells within the
epidermis that give skin its colour.
•The incidence is rising by 3% a year.
•Melanoma is a cancer of melanin producing cells.
•It can arise from skin, mucosa of oropharynx, nasopharynx,
proximal esophagus, anorectum, female genitalia, eyes,
retina, uvea, leptomeninges(arachnoidparameter).

DEFINITION
•Melanoma, the most serious type of skin cancer, which
develops in the cells (melanocytes) that produce
melanin —the pigment that gives the skin its colour.
•Melanoma can also form in the eyes and rarely inside
of the body such as nose or throat.

RISK FACTORS FOR MELANOMA
•Large numbers of benign naevus.
•Clinically atypical naevus.
•Severe sunburn.
•Early years in a tropical climate.

DIAGNOSTIC EVALUATION

MANAGEMENT
•Complete surgical resection.
•In patients with recurrent disease and without
distant disease, a second surgical procedure is
considered as the best option.
•Malignant melanoma has been regarded as a
radio resistant tumour, radio therapy has
become utilized as adjuvant treatment
considering the tumour heterogeneity.
•No systemic therapy has been recognized as
effective for metastatic mucosal melanoma
Tags